Discovery and Characterization of Pure RhlR Antagonists against Pseudomonas aeruginosa Infections

Journal of Medicinal Chemistry
SangJin NamYoungjoo Byun

Abstract

Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic human pathogen that forms biofilms and produces virulence factors via quorum sensing (QS). Blocking the QS system in P. aeruginosa is an excellent strategy to reduce biofilm formation and the production of virulence factors. RhlR plays an essential role in the QS system of P. aeruginosa. We synthesized 55 analogues based on the chemical structure of 4-gingerol and evaluated their RhlR inhibitory activities using the cell-based reporter strain assay. Comprehensive structure-activity relationship studies identified the alkynyl ketone 30 as the most potent RhlR antagonist. This compound displayed selective RhlR antagonism over LasR and PqsR, strong inhibition of biofilm formation, and reduced production of virulence factors in P. aeruginosa. Furthermore, the survival rate of Tenebrio molitor larvae treated with 30in vivo greatly improved. Therefore, compound 30, a pure RhlR antagonist, can be utilized for developing QS-modulating molecules in the control of P. aeruginosa infections.

References

Mar 1, 1983·Reviews of Infectious Diseases·G P BodeyL Jadeja
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·U A Ochsner, J Reiser
Sep 1, 1995·Journal of Industrial Microbiology·J W Costerton
May 1, 1997·Journal of Bacteriology·E C PesciB H Iglewski
Dec 29, 1998·Emerging Infectious Diseases·C Van Delden, B H Iglewski
Dec 23, 1999·Current Opinion in Microbiology·B L Bassler
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Sep 7, 2001·Annual Review of Microbiology·M B Miller, B L Bassler
Mar 5, 2003·Current Opinion in Microbiology·Roger S Smith, Barbara H Iglewski
Jul 5, 2005·Journal of Bacteriology·Amber Lindsay, Brian M M Ahmer
Mar 1, 2006·International Journal of Medical Microbiology : IJMM·Thomas B Rasmussen, Michael Givskov
Jan 16, 2007·Journal of Bacteriology·Sünje Johanna Pamp, Tim Tolker-Nielsen
Aug 7, 2007·Journal of Bacteriology·Hans-Curt FlemmingDaniel J Wozniak
Oct 16, 2007·BioTechniques·Tony J Collins
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Mette E SkindersoeMichael Givskov
Sep 2, 2008·Bioorganic & Medicinal Chemistry Letters·Grant D GeskeHelen E Blackwell
Jul 30, 2011·Bioorganic & Medicinal Chemistry·Christine E McInnis, Helen E Blackwell
Sep 19, 2012·Journal of Computer-aided Molecular Design·Angusamy AnnapooraniArumugam Veera Ravi
Mar 6, 2013·Expert Review of Anti-infective Therapy·Jack N PendletonBrendan F Gilmore
Oct 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Colleen T O'LoughlinBonnie L Bassler
Mar 25, 2014·Current Opinion in Microbiology·Cristina SolanoIñigo Lasa
Feb 24, 2015·ACS Medicinal Chemistry Letters·Kevin T O'BrienLark J Perez
Apr 11, 2015·International Journal of Antimicrobial Agents·Anaïs PotronPatrice Nordmann
Nov 15, 2017·Journal of Medicinal Chemistry·Hyunsuk ChoiYoungjoo Byun
Jun 14, 2019·PLoS Pathogens·Amelia R McCreadyBonnie L Bassler

❮ Previous
Next ❯

Citations

Aug 13, 2021·Scientific Reports·Pedro SeguíMilagros Molina-Alarcón

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.